Previous 10 | Next 10 |
Shares of fledgling healthcare company Livongo Health (NASDAQ: LVGO) dropped 43.1% in September, according to data provided by S&P Global Market Intelligence . The company only recently IPO'd on July 25, but it's been a rocky road since then. September's drop knocked s...
When Livongo (NASDAQ: LVGO) completed its IPO in July, it demonstrated that Wall Street is once again hungry for digital-health startups. The Silicon Valley developer of devices and software for managing diabetes upsized its pricing from an initial range of $20-$23 per share to finally list a...
October 8, 2019 Palm Beach, FL – October 8, 2019 – Medical device manufacturing remains a strong market, driven by technological developments, an aging population, and increases in chronic and lifestyle diseases – trends that expand healthcare spending. W...
The stock market got off to a slow start for the week, with modest losses on Monday that amounted to just a small fraction of a percent for major benchmarks. Investors continued to wrestle with big-picture issues on the macroeconomic and geopolitical fronts, and with earnings season just about t...
Shares of Livongo Health (NASDAQ: LVGO) rose nearly 17% today after the company reported that it was awarded a contract for the Federal Employees Health Benefits Program (FEHBP). The company will be able to supply its Livongo for Diabetes solution to the roughly 5.3 million people in the pro...
Gainers: Akcea Therapeutics (NASDAQ: AKCA ) +29% . Liquid Media Group (NASDAQ: YVR ) +24% . AgeX Therapeutics (NYSEMKT: AGE ) +20% . Sutro Biopharma (NASDAQ: STRO ) +19% . Livongo Health (NASDAQ: LVGO ) +15% . Motus GI Holdings (NASDAQ: MOTS ) +12% . Teekay Tankers (NYSE: TNK )...
Pfenex (NYSEMKT: PFNX ) +13% as FDA OKs Pfenex Forteo biosimilar. More news on: Pfenex Inc., Mereo BioPharma Group plc, Livongo Health, Inc., Stocks on the move, Read more ...
MOUNTAIN VIEW, Calif., Oct. 07, 2019 (GLOBE NEWSWIRE) -- Livongo Health, Inc (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced it was awarded a contract to provide the Livongo for ...
So far, 2019's been a pretty good year for healthcare stocks in general, but a few younger members of the sector have fallen recently. Shares of Guardant Health (NASDAQ: GH) , Livongo Health (NASDAQ: LVGO) , and Masimo (NASDAQ: MASI) have outperformed in the past, but not in recen...
Every fall, pharmaceutical industry leaders, clinicians, and interested observers of all stripes gather at the annual European Society for Medical Oncology (ESMO) Congress to discuss the latest news in the ongoing attempts to cure various types of cancer. This year, a number of companies unveile...
News, Short Squeeze, Breakout and More Instantly...
Would Teladoc (NYSE: TDOC) make a good fit for Berkshire (NYSE: BRK.A) (NYSE: BRK.B) ? In this clip from "The Rank" on Motley Fool Live , recorded on April 25 , Motley Fool contributor Zane Fracek makes the case for why he'd like to see Berkshire expand into heal...
Should You Buy These Health Care Stocks After Its Recent Dips? In the stock market today, investors appear to be cautious toward health care stocks as the COVID-19 vaccine roll-out gathers steam. While the pandemic has without a doubt place an enormous strain on the global healt...
Two of the most high-profile healthcare stocks of 2020, Teladoc Health (NYSE: TDOC) and Livongo Health (NASDAQ: LVGO) , reported third-quarter earnings after the market close last Wednesday. While each company delivered more than 100% top-line growth, both stocks sold off on...